Subsequent Events	9 Months Ended
Sep. 30, 2017
Subsequent Events [Abstract]
Subsequent Events	Note 13 – Subsequent Events On October 5, 2017, the Company agreed to lease from the Company’s CEO, a "420 Style" resort and estate property approximately one hour outside of Quebec City, Canada. The fifteen-acre estate consists of nine (9) unique guest suites, horse stables, and is within walking distance to a public golf course. A separate structure will serve as a small grow facility run by patient employees and caretakers on the property which may be toured by guests of the facility. Pursuant to the agreement, the Company will pay $8,000 per month in exchange for the Company being entitled to al rents and income generated from the property. The Company will be responsible for all costs of the property, including, but not limited to, renovations, repairs and maintenance, insurance and utilities. Prior to the agreement, the Company issued 5,000,000 shares of common stock as a prepayment of future rents. On October 9, 2017, the Company issued 4,340,042 shares of common stock upon the conversion of $30,710 of principal and interest. The shares were issued at $0.007076 per share. On October 11, 2017, the Company signed a LOI with MediK8 Mobile, Inc. (“MediK8”) and Anton Ansalmar, the sole officer of MediK8, whereby the Company and MediK8 will form a Joint Venture (the “JV”) and share revenue on a 50/50 basis on all clients paying a monthly hosting or transaction fee to the JV. The JV will develop a web based and mobile platform and social marketplace, consisting of a HIPPA compliant database of registered patients, consumers and licensed vendors On October 12, 2017, the Company issued 7,512,057 shares of common stock upon the exercise of warrant #1 (see note 9). On October 16, 2017, the company received $75,000 pursuant to a Stock Purchase Agreement by and between the Company and St George. On October 23, 2017, the Company issued 5,057,830 shares of common stock upon the conversion of $30,802 of principal and interest. The shares were issued at $0.00609 per share. On October 27, 2017, the Company entered into a LOI with Corix Bioscience, Inc (“Corix”), whereby Corix would acquire certain assets of the Company in exchange for 5,000,000 shares of Corix common stock. On November 6, 2017, the Company issued 3,536,715 shares of common stock upon the conversion of $20,718 of principal and interest. The shares were issued at $0.005858 per share. On November 6, 2017, the Company issued 6,205,674 shares of common stock upon the conversion of $35,000 of principal and interest. The shares were issued at $0.00564 per share. On November 13, 2017, the company received $35,000 pursuant to a Stock Purchase Agreement by and between the Company and St George. On November 13, 2017, the Company issued 7,121,885 shares of common stock upon the conversion of $41,720 of principal and interest. The shares were issued at $0.005858 per share.

Subsequent Events

9 Months Ended

Sep. 30, 2017

Note 13 – Subsequent Events

On October 5, 2017, the Company agreed to lease from the Company’s CEO, a "420 Style" resort and estate property approximately one hour outside of Quebec City, Canada. The fifteen-acre estate consists of nine (9) unique guest suites, horse stables, and is within walking distance to a public golf course. A separate structure will serve as a small grow facility run by patient employees and caretakers on the property which may be toured by guests of the facility. Pursuant to the agreement, the Company will pay $8,000 per month in exchange for the Company being entitled to al rents and income generated from the property. The Company will be responsible for all costs of the property, including, but not limited to, renovations, repairs and maintenance, insurance and utilities. Prior to the agreement, the Company issued 5,000,000 shares of common stock as a prepayment of future rents.

On October 9, 2017, the Company issued 4,340,042 shares of common stock upon the conversion of $30,710 of principal and interest. The shares were issued at $0.007076 per share.

On October 11, 2017, the Company signed a LOI with MediK8 Mobile, Inc. (“MediK8”) and Anton Ansalmar, the sole officer of MediK8, whereby the Company and MediK8 will form a Joint Venture (the “JV”) and share revenue on a 50/50 basis on all clients paying a monthly hosting or transaction fee to the JV. The JV will develop a web based and mobile platform and social marketplace, consisting of a HIPPA compliant database of registered patients, consumers and licensed vendors

On October 12, 2017, the Company issued 7,512,057 shares of common stock upon the exercise of warrant #1 (see note 9).

On October 16, 2017, the company received $75,000 pursuant to a Stock Purchase Agreement by and between the Company and St George.

On October 23, 2017, the Company issued 5,057,830 shares of common stock upon the conversion of $30,802 of principal and interest. The shares were issued at $0.00609 per share.

On October 27, 2017, the Company entered into a LOI with Corix Bioscience, Inc (“Corix”), whereby Corix would acquire certain assets of the Company in exchange for 5,000,000 shares of Corix common stock.

On November 6, 2017, the Company issued 3,536,715 shares of common stock upon the conversion of $20,718 of principal and interest. The shares were issued at $0.005858 per share.

On November 6, 2017, the Company issued 6,205,674 shares of common stock upon the conversion of $35,000 of principal and interest. The shares were issued at $0.00564 per share.

On November 13, 2017, the company received $35,000 pursuant to a Stock Purchase Agreement by and between the Company and St George.

On November 13, 2017, the Company issued 7,121,885 shares of common stock upon the conversion of $41,720 of principal and interest. The shares were issued at $0.005858 per share.